Regencell Bioscience(us:RGC)
32.90
+28.17%
Updated on 2025-03-31
Open:24.70
Close:32.90
High:39.51
Low:21.00
Prev Close:25.67
Volume:428644.00
Turnover:13.32M
Turnover Ratio:3.29%
Shares:13.01M
MarketCap:428.12M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-03-31 | 3 | 1651 | 0.01% | 0 | 0 | 1 |
| 2023-12-31 | 5 | 16304 | 0.13% | 1 | 0 | 2 |
| 2023-09-30 | 4 | 662 | 0.01% | 2 | 1 | 0 |
| 2023-06-30 | 4 | 539 | 0.00% | 0 | 1 | 2 |
| 2023-03-31 | 4 | 736 | 0.01% | 1 | 1 | 1 |
| 2022-12-31 | 5 | 1188 | 0.01% | 0 | 2 | 2 |
| 2022-09-30 | 5 | 8201 | 0.06% | 0 | 1 | 2 |
| 2022-06-30 | 7 | 8504 | 0.07% | 2 | 3 | 2 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Ubs Group Ag | 1400 | 0.01% | -14653 | -91.28% |
| 2024-03-31 | Blackrock Inc. | 238 | 0.00% | 0 | |
| 2024-03-31 | Qube Research & Technologies Ltd | 13 | 0.00% | 0 | |
| 2023-12-31 | Ubs Group Ag | 16053 | 0.12% | 16053 | |
| 2023-12-31 | Blackrock Inc. | 238 | 0.00% | 0 | |
| 2023-12-31 | Qube Research & Technologies Ltd | 13 | 0.00% | 0 | |
| 2023-12-31 | Tower Research Capital Llc (Trc) | 0 | -85 | ||
| 2023-12-31 | Morgan Stanley | 0 | -326 | ||
| 2023-09-30 | Morgan Stanley | 326 | 0.00% | 25 | 8.31% |
| 2023-09-30 | Blackrock Inc. | 238 | 0.00% | 0 |
About
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
Address:Chinachem Leighton Plaza,29 Leighton Road,9th Floor, Causeway Bay
Market Movers